AXA SA Earnings Calls
| Release date | Aug 01, 2025 |
| EPS estimate | 1.98€ |
| EPS actual | 2.03€ |
| EPS Surprise | 2.53% |
| Revenue estimate | 51.011B |
| Revenue actual | 64.251B |
| Revenue Surprise | 25.96% |
| Release date | Apr 23, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 27, 2025 |
| EPS estimate | 1.72€ |
| EPS actual | 1.77€ |
| EPS Surprise | 2.91% |
| Revenue estimate | 36.136B |
| Revenue actual | 36.517B |
| Revenue Surprise | 1.05% |
| Release date | Oct 30, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | 24.69B |
| Revenue actual | - |
Last 4 Quarters for AXA SA
Below you can see how AXA.DE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 30, 2024 |
| Price on release | 34.81€ |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 24, 2024 | 35.25€ |
| Oct 25, 2024 | 34.90€ |
| Oct 28, 2024 | 35.30€ |
| Oct 29, 2024 | 35.12€ |
| Oct 30, 2024 | 34.81€ |
| Oct 31, 2024 | 34.48€ |
| Nov 01, 2024 | 34.26€ |
| Nov 04, 2024 | 34.03€ |
| Nov 05, 2024 | 34.38€ |
| 4 days before | -1.25% |
| 4 days after | -1.24% |
| On release day | -0.95% |
| Change in period | -2.47% |
| Release date | Feb 27, 2025 |
| Price on release | 37.74€ |
| EPS estimate | 1.72€ |
| EPS actual | 1.77€ |
| EPS surprise | 2.91% |
| Date | Price |
|---|---|
| Feb 21, 2025 | 36.96€ |
| Feb 24, 2025 | 37.10€ |
| Feb 25, 2025 | 37.54€ |
| Feb 26, 2025 | 38.27€ |
| Feb 27, 2025 | 37.74€ |
| Feb 28, 2025 | 37.47€ |
| Mar 03, 2025 | 38.19€ |
| Mar 04, 2025 | 37.98€ |
| Mar 05, 2025 | 38.32€ |
| 4 days before | 2.11% |
| 4 days after | 1.54% |
| On release day | -0.715% |
| Change in period | 3.68% |
| Release date | Apr 23, 2025 |
| Price on release | 40.32€ |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 15, 2025 | 38.90€ |
| Apr 16, 2025 | 39.17€ |
| Apr 17, 2025 | 39.50€ |
| Apr 22, 2025 | 40.03€ |
| Apr 23, 2025 | 40.32€ |
| Apr 24, 2025 | 40.21€ |
| Apr 25, 2025 | 40.58€ |
| Apr 28, 2025 | 40.93€ |
| Apr 29, 2025 | 41.33€ |
| 4 days before | 3.65% |
| 4 days after | 2.50% |
| On release day | -0.273% |
| Change in period | 6.25% |
| Release date | Aug 01, 2025 |
| Price on release | 39.36€ |
| EPS estimate | 1.98€ |
| EPS actual | 2.03€ |
| EPS surprise | 2.53% |
| Date | Price |
|---|---|
| Jul 28, 2025 | 42.15€ |
| Jul 29, 2025 | 42.50€ |
| Jul 30, 2025 | 42.63€ |
| Jul 31, 2025 | 42.70€ |
| Aug 01, 2025 | 39.36€ |
| Aug 04, 2025 | 40.01€ |
| Aug 05, 2025 | 40.58€ |
| Aug 06, 2025 | 40.75€ |
| Aug 07, 2025 | 41.56€ |
| 4 days before | -6.62% |
| 4 days after | 5.59% |
| On release day | 1.65% |
| Change in period | -1.40% |
AXA SA Earnings Call Transcript Summary of Q2 2025
AXA delivered a strong H1 2025: Group revenue rose ~7% to above €64bn, underlying earnings increased ~6% to €4.5bn and underlying EPS grew ~8% (at the upper end of the Unlock the Future plan range). Solvency II remains very strong (c.220%), with the group generating around 15 solvency points per half-year and preserving capital flexibility for buybacks and selective bolt-on M&A. Business-line performance was broad-based: P&C revenues +6% (combined ratio ~90%, nat-cat loss ratio ~3%), Life & Health revenues +8% (life +9%, health GWP +6%), and reinsurance growth of ~11%. AXA completed the disposal/partnership of AXA IM (effective 1 July) and is refocusing on “insurance, only insurance”; it announced the acquisition of 51% of Prima (Italy, ~€500m), which materially strengthens its direct motor footprint in Italy (direct channel revenues across the group rising from ~€3.5bn to ~€4.7bn). Management emphasised continued investment in data/AI and distribution expansion (agents, salaried salesforce, and direct channels) while prioritising organic growth and disciplined, opportunistic M&A. Near-term drivers to monitor: integration and synergies from Prima/Nobis in Italy, the AXA IM transition impacts on flows and earnings recognition, claims and pricing dynamics in UK motor, continued capital return (buybacks) and solvency/headroom evolution.
Sign In
Buy AXA